prostate specific antigen (PSA)

November 11, 2019

Men with BRCA2 Mutations Should Get Regular PSA Screening, Phase 3 Interim Data Suggest

News

Prostate-specific antigen (PSA) testing — a controversial approach to detecting prostate cancer — spotted the cancer more often, at a younger age, and in more serious forms in men older ... Read more

June 20, 2019

Investigational AMG 212 Shows Anti-cancer Activity in Advanced mCRPC in Phase 1 Trial

News

Amgen’s investigational therapy AMG 212 (pasotuxizumab) is safe, and showing therapeutic activity against metastatic castration-resistant prostate cancer (mCRPC) in a Phase 1 clinical trial, data show. This is the first ... Read more

February 18, 2019

Prostate Cancer UK Grants $355K to University of Birmingham for Development of New Test

News

Prostate Cancer UK has awarded more than $355,000 (£275,000) to University of Birmingham researchers to develop a diagnostic tool that can measure the aggressiveness of a patient’s prostate cancer. The new ... Read more

October 31, 2018October 31, 2018

Baseline PSA Screening During Midlife Predicts Prostate Cancer in Black Men, Study Finds

News

Measuring PSA levels during midlife — between 40 and 64 years — could help predict the likelihood an African-American man has of developing prostate cancer up to 12 years after ... Read more

August 6, 2018

Long-term Use of Cholesterol-lowering Medications May Benefit Some Prostate Cancer Patients, Trial Shows

News

Long-term treatment with atorvastatin, a cholesterol-lowering medicine, may reduce the proliferation of prostate cancer cells in some patients, a randomized trial suggests. Results from the trial were published in the study, ... Read more

February 12, 2018February 13, 2018

Xtandi Reduces Risk of Metastasis in Castration-resistant Prostate Cancer, Phase 3 Trial Shows

News

Treatment with Xtandi (enzalutamide) reduced the risk of metastasis or death in castration-resistant prostate cancer (CRPC) patients whose cancer has not yet spread beyond the prostate, Pfizer and Japan-based Astellas Pharma recently ... Read more

May 1, 2017May 1, 2017

Prostate Cancer’s Aggressive Nature in Black Americans Suggests Need for More Personalized Screening

News

The higher rates at which black men are dying of prostate cancer may be linked to faster disease progression, according to a new study. The results suggest that African-Americans should ... Read more

September 8, 2016September 8, 2016

PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola

News

Detecting the exact location and extent of prostate cancer that has returned and metastasized in patients after initial treatment is now more likely, following the recent approval of a new positron emission tomography ... Read more

September 7, 2016September 7, 2016

Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients

News

A mathematical model based on four consecutive measures of prostate-specific antigen (PSA) levels can be used to predict the time to relapse in patients who underwent prostate cancer surgery, according to ... Read more